Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic adjuvant therapy for breast cancer

M J Kennedy1

  • 1Johns Hopkins Oncology Center, Baltimore, Maryland.

Current Opinion in Oncology
|November 1, 1994
PubMed
Summary

Systemic adjuvant therapy offers modest breast cancer mortality reduction. Future research aims to enhance treatment efficacy and reduce toxicity by targeting high-risk patients, improving outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The incidence of arthrogenic muscle inhibition in acute knee injuries: a prospective cohort study in a tertiary acute knee unit.

Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology·2025
Same author

Simultaneous "fix and replace" has non inferior survivorship compared to staged arthroplasty in acetabular fracture management at two year follow up.

Injury·2025
Same author

CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in Ireland.

Irish journal of medical science·2025
Same author

Heterogeneous integration of a III-V quantum dot laser on high thermal conductivity silicon carbide.

Optics letters·2023
Same author

Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.

Breast cancer research and treatment·2021
Same author

Low loss (Al)GaAs on an insulator waveguide platform.

Optics letters·2019

Area of Science:

  • Oncology
  • Cancer Research
  • Pharmacology

Background:

  • Systemic adjuvant therapy provides a modest reduction in breast cancer mortality.
  • Current strategies aim to improve treatment efficacy and minimize toxicity.
  • Understanding metastasis and cytotoxic mechanisms is key for future advancements.

Purpose of the Study:

  • To review current research directions in systemic adjuvant therapy for breast cancer.
  • To discuss strategies for increasing treatment efficacy and reducing toxicity.
  • To highlight the importance of understanding the metastatic process and treatment mechanisms.

Main Methods:

  • Literature review of current research in breast cancer adjuvant therapy.
  • Analysis of strategies for enhancing treatment intensity and reducing side effects.
  • Examination of cost-benefit analyses for adjuvant systemic therapies.

Main Results:

  • Systemic adjuvant therapy offers a modest but significant reduction in breast cancer mortality.
  • Research is focused on increasing treatment intensity for efficacy and reducing toxicity by targeting high-risk patients.
  • Cost-benefit analyses support the use of adjuvant therapies for patients with a significant risk of recurrence.

Conclusions:

  • Further understanding of the metastatic process and cytotoxic treatment mechanisms is crucial for developing more effective breast cancer therapies.
  • Adjuvant systemic therapies are cost-effective for patients at significant risk of recurrence.
  • Personalized treatment approaches based on relapse risk are essential for optimizing patient outcomes.

Related Experiment Videos